WHO names COVID-19 variants 1st found in India as 'Kappa' and 'Delta'
- United States
The B.1.617.1 and B.1.617.2 variants of the COVID-19, first identified in India, have been named as 'Kappa' and 'Delta' respectively by the WHO as they named various variants of the coronavirus using Greek alphabets to simplify public discussions and also help remove the stigma from the names.
The World Health Organisation's move on Monday came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an ''Indian Variant'' in media reports with the Union Health Ministry pointing out that the UN's top health organ has not used the word ''Indian'' for this strain in its document.
The UN health agency named the B.1.617.1 variant of the COVID 19 as 'Kappa' while the B1.617.2 variant was dubbed 'Delta.' Both the variants were first found in India.
Taking to Twitter, Dr. Maria Van Kerkhove, WHO's technical COVID-19 lead, on Monday said: ''Today, @WHO announces new, easy-to-say labels for #SARSCoV2 Variants of Concern (VOCs) & Interest (VOIs). They will not replace existing scientific names, but are aimed to help in public discussion of VOI/VOC".
The WHO, while announcing the new naming system "making them simple, easy to say and remember", said that it is "stigmatizing and discriminatory" to call the variants by names of the nations they are first detected in.
"The labels do not replace existing scientific names, which convey important scientific information & will continue to be used in research. The naming system aims to prevent calling COVID-19 variants by the places where they are detected, which is stigmatizing & discriminatory," the WHO said in a tweet on Monday.
The Geneva-based global health agency encouraged countries and others to adopt these names as they will ease public discussions about the global COVID-19 Variants of Concern and Interest.
The B.1.1.7 strain first detected in the UK will be known as "Alpha", while the B.1.351 variant detected in South Africa is now 'Beta', P.1 variant first found in Brazil is "Gamma" and the P.2 variant is "Zeta". The strains found in the US are "Epsilon" and "Iota".
"No country should be stigmatized for detecting and reporting variants. Globally, we need robust surveillance for variants, incl epi, molecular, and sequencing to be carried out and shared. We need to continue to do all we can to reduce the spread of SARS-CoV-2 (sic)," Infectious Disease Epidemiologist and COVID-19 Technical Lead at the WHO Kerkhove said in a tweet.
"The labels don't replace existing scientific names, which convey (important) scientific info and will continue to be used in research… These labels will help with a public discussion about VOC/VOI as the numbering system can be difficult to follow," she said.
To assist with public discussions of variants, the WHO convened a group of scientists from the WHO Virus Evolution Working Group, the WHO COVID-19 reference laboratory network, representatives from GISAID, Nextstrain, Pango, and additional experts in virological, microbial nomenclature and communication from several countries and agencies to consider easy-to-pronounce and non-stigmatizing labels for VOIs and VOCs.
''At present, this expert group convened by WHO has recommended labels using letters of the Greek Alphabet, i.e., Alpha, Beta, Gamma, which will be easier and more practical to discuss by non-scientific audiences," the WHO added.
On May 12, India's health ministry dismissed it as ''without any basis and unfounded'' media reports that used the term ''Indian variant'' for the B.1.617 mutant strain, which the WHO recently said was a ''variant of global concern''.
''Several media reports have covered the news of the World Health Organization (WHO) classifying B.1.617 as a variant of global concern. Some of these reports have termed the B.1.617 variant of the coronavirus as an 'Indian Variant','' the ministry said in a statement in New Delhi.
''These media reports are without any basis, and unfounded,'' it said.
The WHO said that the ''established nomenclature systems for naming and tracking SARS-CoV-2 genetic lineages by GISAID, Nextstrain and Pango are currently and will remain in use by scientists and scientific research.'' The WHO and its international networks of experts are monitoring changes to the virus.
''If significant mutations are identified, we can inform countries and the public about any changes needed to react to the variant, and prevent its spread," it added.
Globally, systems have been established and are being strengthened to detect "signals" of potential VOCs and VOIs and assess these based on the risk posed to global public health.
National authorities may choose to designate other variants of local interest/concern, it added.
China reported the first COVID-19 case in the central Chinese city of Wuhan in late 2019 and since then the deadly disease has become a pandemic. China had also reacted angrily after former US President Donald Trump repeatedly referred to the coronavirus as "China virus".
According to Johns Hopkins University, the coronavirus has so far infected more than 170,585,200 people and killed over 3,546,900 people across the world.
On Tuesday, India reported 1,27,510 fresh COVID-19 cases, the lowest in 54 days, taking the country's tally to 2,81,75,044, according to the Union Health Ministry.
The COVID-19 death toll climbed to 3,31,895 with 2,795 fresh fatalities, the lowest reported in 35 days, and the active cases were recorded below 20 lakh after 43 days.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)